HK1 and nasopharyngeal carcinoma: Intriguingly, although NPC53 was identified with genetic mutations in CYLD and TRAF3, which is a genetic signature for EBV+ve NPC, the transcriptome profile of NPC53 revealed an inactivated NF-κB signaling and clustered with HK1 and NPC38.